Pages

Monday, April 28, 2014

Athersys stem-cell therapy for bowel disease fails in study

Athersys Inc said its experimental stem-cell therapy for treating an inflammatory bowel disease failed to show any benefit in patients in a mid-stage trial.

http://ift.tt/1ivIIVY

No comments:

Post a Comment